Pharmacotherapy of hepatitis C virus infection: a brief review.
Infection with the hepatitis C virus is a major public health problem and is the leading cause of liver disease in the United States. Chronic infection with hepatitis C virus can lead to liver disease, cirrhosis, and hepatocellular carcinoma. Treatment options include interferon or peginterferon, and ribavirin. The objective of treatment is to eradicate the infection in an effort to prevent complications of hepatitis C virus infection.
Quan
David J
DJ
UCSF Medical Center, San Francisco, CA, USA.
D000998:Antiviral Agents / Q000627:therapeutic use*; D006526:Hepatitis C / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications
D000998:Antiviral Agents